‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countriesnews2023-02-07T21:15:45+00:00February 7th, 2023|The New York Times|
Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertainnews2022-09-27T07:00:12+00:00September 27th, 2022|The New York Times|
In South Africa, Success Against H.I.V. Offers Hopenews2022-01-11T14:59:11+00:00January 11th, 2022|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutationsnews2021-12-04T18:53:12+00:00December 4th, 2021|The New York Times|
South African Company Nears License to Sell J. & J. Covid Shot Across Africanews2021-11-30T21:07:51+00:00November 30th, 2021|The New York Times|
An Experimental H.I.V. Vaccine Fails in Africanews2021-08-31T11:50:11+00:00August 31st, 2021|The New York Times|
What to Know About Boosters if You Got the Johnson & Johnson Vaccinenews2021-08-19T00:52:34+00:00August 19th, 2021|The New York Times|
